Thursday, 20 Sep 2018

You are here

Dr. Len Calabrese - EULAR 2018 Vasculitis Update on C5a Receptor Inhibitor

EULAR studies on avacopan (CCX168), an oral selective C5a receptor inhibitor

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – 10...

10 Feb 2017

Dr. Anne Stevens: Pediatric...

09 Feb 2018

Dr. Ronan Kavanagh: The greatest...

14 Nov 2016

Dr. Umber Ahmad: Cutaneous Polyarteris...

11 Feb 2018

Dr. Martin Bergman: Meta-analysis and...

09 Feb 2018

Dr. Sheetal Patel: Multicentric...

11 Feb 2018

RheumNow (ACR16) Week in Review – 18...

18 Nov 2016

Dr. Paul Sufka: Managing Online...

07 Nov 2017

Dr. Philip Robinson at EULAR 2018 on...

20 Jun 2018

Dr. Janet Pope: Pre-op for Total Hip or...

07 Nov 2017

The RheumNow Week in Review – 17...

17 Feb 2017

The RheumNow Week in Review – Cocoon...

20 Jul 2018